TrialGenetic testing and molecular biomarkers2012

Low expression of stathmin in tumor predicts high response to neoadjuvant chemotherapy with docetaxel-containing regimens in locally advanced breast cancer.

Xu-Li Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.